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ABSTRACT
High mobility group N (HMGN) is a family of intrin-
sically disordered nuclear proteins that bind to nu-
cleosomes, alters the structure of chromatin and
affects transcription. A major unresolved question
is the extent of functional specificity, or redundancy,
between the various members of the HMGN protein
family. Here, we analyze the transcriptional profile of
cells in which the expression of various HMGN
proteins has been either deleted or doubled. We
find that both up- and downregulation of HMGN ex-
pression altered the cellular transcription profile.
Most, but not all of the changes were variant
specific, suggesting limited redundancy in tran-
scriptional regulation. Analysis of point and swap
HMGN mutants revealed that the transcriptional
specificity is determined by a unique combination
of a functional nucleosome-binding domain and
C-terminal domain. Doubling the amount of HMGN
had a significantly larger effect on the transcription
profile than total deletion, suggesting that the intrin-
sically disordered structure of HMGN proteins plays
an important role in their function. The results reveal
an HMGN-variant-specific effect on the fidelity of
the cellular transcription profile, indicating that
functionally the various HMGN subtypes are not
fully redundant.
INTRODUCTION
The dynamic architecture of the chromatin ﬁber plays a
key role in regulating transcriptional processes necessary
for proper cell function and mounting adequate responses
to various internal and external biological signals.
Architectural nucleosome-binding proteins such as the
linker histone H1 protein family and the high mobility
group (HMG) protein superfamily are known to continu-
ously and reversibly bind to chromatin, transiently
altering its structure and affecting the cellular transcrip-
tion output (1,2). Although extensively studied, the
cellular function and mechanism of action of these
chromatin-binding architectural proteins are still not
fully understood. A major question in this ﬁeld is the
extent of the functional speciﬁcity of the structural
variants of histone H1 or of the various HMG families
(3–6). Experiments with genetically altered mice lacking
one or several H1 variants revealed that loss of one
variant leads to increase synthesis of the remaining
variants, suggesting functional redundancy between H1
variants (7,8). Yet, analysis of cells in which the levels of
speciﬁc H1 variants have been altered suggests a certain
degree of variant-speciﬁc effects on transcriptional output
(9–11)
The HMG superfamily is composed of three families
named HMGA, HMGB and high mobility group N
(HMGN), each containing several protein members
(3,4). It is known that HMG proteins affect transcription
and modulate the cellular phenotype (12); however, the
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has not yet been systematically studied. Here, we
examine the role of the various HMGN variants in the
regulation of the cellular transcription proﬁle.
The HMGN family of chromatin architectural proteins
consists of ﬁve members with a similar structure (13).
All contain a bipartite nuclear localization signal
(NLS), a highly conserved nucleosome-binding domain
(NBD) and a negatively charged and highly disordered
C-terminal domain. The HMGNs are the only nuclear
proteins known to speciﬁcally recognize generic structural
features of the 147-bp nucleosome core particle (CP), the
building block of the chromatin ﬁber (3,4). HMGN binds
to chromatin and CP without any known speciﬁcity for
the sequence of the underlying DNA. In the nucleus,
HMGNs are highly mobile moving among nucleosomes
in a stop-and-go manner (2,14). The fraction of time that
an HMGN resides on a nucleosome (stop period) is longer
than the time it takes to ‘hop’ from one nucleosome to
another; therefore, most of the time, most of the HMGNs
are bound to chromatin. The amount of HMGN present
in most nuclei is sufﬁcient to bind only  1% of the nu-
cleosomes; however, the dynamic binding of HMGNs
to chromatin ensures that potentially every nucleosome
will temporarily interact with an HMGN molecule.
Thus, potentially, HMGNs may affect the transcription
of numerous genes.
HMGN variants share several functional properties,
such as binding afﬁnity to nucleosomes in vitro and
in vivo, competition with linker histone H1 for the
binding sites on nucleosomes, and effects on chromatin
architecture. Likewise, both HMGN1 and HMGN2, the
most abundant and ubiquitous members of this protein
family, form multiple complexes with nuclear proteins
(15). These ﬁndings, and the similarity of their domain
structure, suggest that by enlarge, HMGN proteins
could be functionally redundant. Yet, several studies
indicate that HMGN proteins are not fully redundant.
Both in vivo and in vitro studies indicate that the inter-
action of HMGN variants with CPs lead to the formation
of complexes containing two molecules of a single type of
variant; CPs containing two different HMGN variants are
not formed under physiological conditions (16,17).
In addition, while HMGN1 and HMGN2 seem to be ubi-
quitously expressed, HMGN3 and HMGN5 proteins
show distinct developmental and tissue-speciﬁc expression
(18–20). Most signiﬁcantly, analysis of genetically altered
mice and cells revealed variant-speciﬁc phenotypes and
indication that the variants are not fully functionally re-
dundant (12).
It has been repeatedly shown that interaction of
HMGNs with chromatin affects transcription (21–24).
However, the extent of speciﬁcity of HMGN variants in
transcriptional regulation and the level of functional re-
dundancy between them remain largely unknown, mainly
because of the lack of systematic analysis of the effect of
HMGNs on gene expression in a uniﬁed experimental
system.
To gain insights into the extent of transcriptional spe-
ciﬁcity of the HMGN variants, we compared expression
proﬁles of mouse embryonic ﬁbroblasts (MEFs) in which
various HMGN variants were either knocked out or
stably overexpressed, to double their cellular content.
We found that loss of proteins affected the expression of
a limited number of genes, while doubling the cellular
levels of an HMGN variant affected the expression of
hundreds of genes. While some of the genes were
affected by more than one variant, the great majority of
the genes were affected in a variant-speciﬁc manner.
Intrinsically disordered proteins are predicted to affect
transcription even at low dosage overexpression because
they form weak interactions with multiple partners
(25,26). Thus, the signiﬁcant transcriptional effects result-
ing from doubling the amount of HMGNs is in agreement
with the highly intrinsically disordered structure of
HMGN proteins and with their tendency to form
multiple metastable protein complexes (15). We also
found that speciﬁc variants affect the transcription
proﬁle in a cell-speciﬁc manner. Analysis of domain
swap mutants suggests that the speciﬁcity of each
HMGN is determined by a unique combination of a func-
tional NBD and a C-terminal domain.
The results reveal an HMGN-variant-speciﬁc effect on
the global transcription proﬁle suggesting that these
proteins ﬁne tune the ﬁdelity of the cellular transcription.
We speculate that part of their speciﬁcity is due to their
intrinsic highly disordered structure that enables each
variant to form multiple types of complexes with nuclear
components.
EXPERIMENTAL PROCEDURES
Isolation of MEFs and generation of stable cell lines
Mouse embryonic ﬁbroblasts SV-40 transformed (MEFs)
were purchased from ATCC.
MIN6 cell line was a gift from A.L.Notkins, NIDCR,
NIH. Primary MEFs from variant-speciﬁc knock out mice
were isolated from two embryos as described (27) and
analyzed separately. Cells were grown in Dulbecco’s
Modiﬁed Eagle Medium (DMEM) supplemented with
10% Fetal Calf Serum (FCS).
Retroviruses were produced in Phoenix helper cell line
transfected with the pHAN vector bearing various
HMGN proteins tagged with FLAG and HA at
C-terminus. Stable cell lines were generated by retroviral
infection in the presence of polybrene at the concentration
of 5mg/ml and subsequent selection with puromycin at the
concentration of 1mg/ml for 7 days. Cells were grown
without antibiotics for 1day prior to collecting samples
for expression analysis and western blotting.
Antibodies and western blotting
All the antibodies used in the study were from our
laboratory. Secondary Horseradish Peroxidase (HRP)-
Conjugated antibodies were from Pierce.
Whole cell lysates were prepared in 2  Laemmli sample
buffer (Bio-Rad) supplemented with protease inhibitors.
Samples were separated on 15% pre-cast Criterion gels,
transferred by semi-dry method to polyvinylidene
diﬂuoride (PVDF) membrane, blocked with non-fat milk
in Phosphate Buffered Saline (PBS) and probed with
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enhanced chemiluminescence (ECL) Detection Reagent
(Amersham) was done according to the manufacturer’s
recommendations.
RNA preparation
RNA was prepared by TRIzol reagent according to the
manufacturer’s protocol. Subsequently, RNA was cleaned
up by Qiagen RNeasy kit with on-column DNaseI
treatment.
Gene arrays. Microarray expression analysis was per-
formed using Affymetrix Mouse GeneChips 430 2
(430v2). Hybridization of biotin-labeled cRNA fragment
to Mouse Genome 430 2.0 array, washing, staining
with streptavidin–phycoerythrin (Molecular Probes), and
signal ampliﬁcation were performed according to the
manufacturer’s instructions at the Laboratory of
Molecular Technology (LMT, Frederic, NCI).
Statistical analysis
We analyzed 51 array data sets (n=3 for each particular
experiment) to search for genes whose expression levels
were signiﬁcantly altered. All analyses were performed
using R and BioConductor (28). R packages ‘affy’ (29)
and ‘simpleaffy’ (30) and ‘affyQCReport’ (31) were
employed to evaluate the quality of the arrays by means
of images, histograms, box plots, degradation plots and
scatter plots. Expression values were derived using the
Robust Multichip Average protocol (32) with default
settings. All analyses were done at the so-called sequence
level, i.e. data from probes representing the same gene
were combined. We did not apply any unspeciﬁc ﬁlter
on the expression values.
Differentially expressed genes were identiﬁed using
an empirical Bayes method implemented in the R
package ‘Limma’ (33). P-values were corrected for
multiple testing using a false discovery rate method (34).
Genes for which the adjusted P-value was <0.001
(overexpression of different HMGN variants) or <0.05
(knock out of different HMGN variants) in at least one
of the comparisons were considered differentially ex-
pressed. No fold-change cut-off was applied.
Mouse Genome 430 2.0 array has 45101 probe sets
associated with approximately 20000 Mouse Genome
Informatics (MGI) gene identiﬁers. Probe sets were
mapped to MGI identiﬁers using information provided
by the Jackson Laboratory (http://www.informatics.jax
.org/).
Venn diagrams
Differentially expressed genes in all experiments were
compared to controls and represented as Venn diagrams
(R package ‘Vennerable’) (35).
Functional analysis
Functional analysis of microarray data was based on
overrepresentation of GO terms (36). P-values were cor-
rected for multiple comparisons using Bonferroni’s
method.
Bioinformatics structural analysis
Composition proﬁling. Analysis of amino acid com-
position of HMGN proteins was performed using
Composition Proﬁler online service (http://www
.cproﬁler.org) (37) with default settings. The following ref-
erence protein sets were used: DisProt 3.4 (38), PDB Select
25 (39) and mouse HMGN proteins. The set DisProt 3.4
comprises consensus sequences of experimentally
determined disordered regions; PDB Select 25 contains
PDB structures with <25% sequence identity, biased
toward the composition of proteins amenable to crystal-
lization studies. Amino acids are arranged in the order of
increase of their disorder propensity, according to the
scale by Radivojac et al. (40).
Intrinsic disorder prediction. Per-residue predictions of in-
trinsic disorder in HMGN proteins were performed using
a PONDR VLXT predictor, access to which was
provided by Molecular Kinetics, Inc. (http://www.pondr
.com). PONDR (Predictor OfN atural Disordered
Regions) is a set of neural network predictors of dis-
ordered regions on the basis of local amino acid compos-
ition, ﬂexibility, hydropathy, coordination number and
other factors. These predictors classify each residue
within a sequence as either ordered or disordered.
PONDR VL-XT integrates three feed forward neural
networks: the Variously characterized Long, version 1
(VL1) predictor (41), which predicts non-terminal
residues, and the X-ray characterized N- and C-terminal
predictors (XT) (42), which predicts terminal residues.
Output for the VL1 predictor starts and ends 11 amino
acids from the termini. The XT predictor output provides
predictions up to 14 amino acids from their respective
ends. A simple average is taken for the overlapping pre-
dictions; a sliding window of nine amino acids is used to
smooth the prediction values along the length of the
sequence. Unsmoothed prediction values from the XT
predictors are used for the ﬁrst and last four sequence
positions.
RESULTS
Structural characterization of HMGN variants
Examination of the structure of genes coding for the
various members of the HMGN family suggests that
they originated from a common ancestor. All the genes
contain relatively long 50- and 30-untranslated regions,
six exons and the boundaries of the ﬁrst four exons are
highly conserved (Figure 1A). The gene coding for
HMGN5 evolved recently because it is found only in
mammals. All the proteins encoded by the genes contain
a positively charged, highly conserved, NBD (Figure 1A)
that serves as their main chromatin-binding site.
Embedded in the NBD is the sequence RRSARLSA
(K,M)P that has been shown to be the core sequence
that speciﬁcally anchors HMGN proteins to the 147-bp
nucleosome CP, the building block of the chromatin ﬁber
(43). A NLS that is localized at the N-terminal part of the
proteins is also highly conserved in all HMGN variants.
The C-terminal region of the proteins, encoded by exons
4078 Nucleic Acids Research, 2011,Vol.39, No. 10Figure 1. HMGN proteins are intrinsically disordered. (A) Multiple sequence alignment of mouse HMGN1, HMGN2, HMGN3a and HMGN5
proteins by ClustalW. Only the ﬁrst 94 amino acids of HMGN5 are aligned. The positively charged NBD, the hallmark of HMGN proteins, is
shaded by a blue square. The core sequence of NBD that is conserved in all HMGN proteins is labeled in red. The exon structure of the HMGN
genes is color-coded over the sequences; numbers over the exons correspond to the last amino acid encoded by the exons of the Hmgn2 gene because
HMGN2 is the most evolutionarily conserved HMGN variant. Asterisks indicate identical amino acid, colon indicates conserved substitutions and
dot indicates semi-conserved substitutions. The alignment of HMGN5 is separate from that of HMGN1-3. NLS, nuclear localization signal; RD,
regulatory domain. Solid arrow indicates the position of the swap tail mutants (Figure 4). (B) Relative amino acid composition of various HMGN
proteins in comparison with ordered proteins. Bars are calculated as C(x)   C(order)/C(order), where C(x) is the content of a given residue in
HMGN and C(order) is its content in ordered proteins from Protein Data Bank (http://www.pdb.org/pdb/home/home.do). Negative bars correspond
to residues underrepresented in HMGN, whereas positive bars correspond to residues overrepresented in HMGN. Data for typical intrinsically
disordered proteins are shown for comparison (DisProt, http://www.disprot.org, black bars). Sets of bars correspond to mean values for all HMGNs
(HMGN) as well as for individual HMGNs (HMGN1, HMGN2, HMGN3a and HMGN5). The graph demonstrates that potentially HMGNs are
more disordered than the averaged disordered proteins. (C) PONDR VL-XT disorder prediction for mouse HMGNs. In PONDR plots, segments
with scores >0.5 correspond to the disordered regions, whereas those <0.5 correspond to the ordered regions/binding sites. Note that disorder
distribution in NBD (residues 18–42) is conserved for HMGN1, HGMN2 and HGMN3a. HGMN5 shows much less disorder conservation.
(D) Predicting potential binding sites by ANCHOR algorithm. Potential binding sites are indicated by blue boxes.
Nucleic Acids Research, 2011,Vol.39, No. 10 40795 and 6, differs signiﬁcantly among the HMGN variants.
The HMGN5 C-terminal domain is especially long and
contains several repeats of a negatively charged sequence
motif (18). The alignment shown in Figure 1A illustrates
the major similarities and differences between the mouse
HMGN variants. Mouse HMGN1, HMGN2 and
HMGN3a are similar in size, ranging between 89 and 95
amino acids, and are more similar to each other than to
HMGN5, which is 406 amino acid long. The alignment
does not contain the splice variant HMGN3b, which lacks
the 21 C-terminal residues of HMGN3a, nor the HMGN4
variant, which has not yet been investigated in detail.
Analysis of the amino acid composition of the HMGN
proteins in comparison to ordered proteins listed in
the Protein Data Bank (http://www.pdb.org/pdb/home/
home.do) reveals that potentially all HMGNs are highly
disordered proteins (Figure 1B). in fact, HMGNs are
expected to be signiﬁcantly more disordered than an
‘average’ disordered protein, because they are much
more depleted in major order-promoting residues
(compare the colored bars with negative values for
various HMGNs with the black bars for Intrinsically
Disordered Proteins at the left side of the plot) and are
signiﬁcantly enriched in major disorder-promoting
residues (right side of the plot). Interestingly, the
HMGN variants are different from each other and show
signiﬁcant variability in amino acid compositions, as
exempliﬁed by the large variations in R, T, D, G, A, S,
E and P.
In agreement with intrinsic disorder prediction of
HMGN proteins based on amino acid composition,
PONDR analysis (41,44) predicts a high degree of struc-
tural disorder in all HMGN variants, with a few short
regions with increased order propensity (Figure 1C, dips
in the graph). These relatively ordered regions often
correspond to potential binding sites that fold upon inter-
action with binding partners (45–47). Notably, all
HMGNs contain several regions that according to the
ANCHOR algorithm (48) are predicted to serve as
binding sites for other interacting proteins (Figure 1D),
an observation fully compatible with our previous
ﬁndings that both HMGN1 and HMGN2 can be found
in numerous metastable multiprotein complexes (15). The
number and localization of the predicted protein binding
sites although highly similar are not identical between
HMGN variants.
In summary, although all HMGNs share several
physical properties and are nuclear proteins that bind to
nucleosome CPs through a highly conserved domain, each
variant has a distinct structure and has several sites for
interacting with other proteins. These characteristics raise
the possibility of HMGN-variant-speciﬁc effects on the
cellular transcription proﬁle.
Transcriptional impact of HMGN proteins
To investigate the transcriptional speciﬁcity of HMGN
variants we ﬁrst analyzed the transcriptional proﬁle of
primary MEFs isolated form Hmgn1
 / , Hmgn3
 /  and
Hmgn5
 /  mice using mouse 430.2 Affymetrix expression
arrays. Hmgn2
 /  are not available because these mice are
embryonic lethal (M.B. unpublished data). The results
reveal variant-speciﬁc changes in gene expression proﬁle;
no overlap was observed for the genes affected by the
knockout of different HMGN variants (Figure 2A). The
changes involved both up- and downregulation of tran-
script levels, a ﬁnding that is fully compatible with the
notion that HMGNs enhance transcriptional ﬁdelity by
affecting chromatin structure and optimizing the ﬁdelity
of transcription. Even though transcription of a relatively
small number of genes was affected, Gene Ontology (GO)
analysis revealed signiﬁcant enrichment in a few
non-overlapping pathways for Hmgn1
 / , Hmgn3
 / 
MEFs (Figure 2B). These results are in agreement with
our previous observations that the phenotypes of
Hmgn1
 /  and Hmgn3
 /  mice are distinct but not
severe (19,49).
Because HMGN proteins are intrinsically disordered
proteins (Figure 1) and because dosage changes in such
proteins may lead to large changes in transcription (25),
we reasoned that a mild increase in the cellular levels of
HMGN variants, in a uniform system, may give a more
sensitive indication of the potential transcriptional speci-
ﬁcity of the HMGN variants. To compare the effect of the
overexpression of HMGN variants on transcription in a
uniform system, we used retroviral infection to generate
MEFs cell lines stably expressing speciﬁc HMGN variants
tagged with FLAG and HA at their C-terminus. Vectors
expressing HMGN1, HMGN2, HMGN3a, HMGN5 and
the HMGN5-S17,21E double-point mutant, which does
not bind to chromatin (18), were generated and efﬁciently
expressed in MEFs. Following infection, cells were sub-
jected to the selection procedure and all the cells that
passed the selection were analyzed as a pool.
Western blot analysis of the infected cells revealed
that the level of expression of each exogenous protein
Figure 2. Effects of HMGNs knock out on transcription in primary
MEFs. (A) Venn diagrams of down- and upregulated genes in primary
MEFs. (B) GO analysis of affected genes (P <0.05).
4080 Nucleic Acids Research, 2011,Vol.39, No. 10was comparable to the level of its endogenous counterpart
(Figure 3A). Thus, stably infected MEFs express  2-fold
higher levels of a speciﬁc HMGN variant. The HMGN5-
S17,21E protein contains mutations in two serine residues
in the NBD which abolish its binding to nucleosomes
(18) and thus served as a control for transcriptional
effects due to chromatin binding. As an additional
control, we infected MEFs with virus carrying an empty
vector. For each variant, we analyzed the transcription
proﬁle of three independently infected pools of MEFs
using mouse 430.2 Affymetrix expression arrays.
We compared the transcription proﬁle of MEFs over-
expressing speciﬁc HMGN variants to the control cell
lines transfected with empty vectors or with the
HMGN5-S17,21E double-point mutant.
Class comparison between cell lines indicated that
overexpression of HMGNs altered the expression level
of 5203 genes. Three-dimensional clustering of these tran-
scripts, based on principal component analysis (PCA),
revealed that the various cell lines formed four distinct
expression clusters (Figure 3B). Three of the clusters
were formed by the cell overexpressing either HMGN1,
Figure 3. Effects of elevated expression of HMGNs on transcription in MEFs. (A) Western blot analysis of stably infected MEFs. Shown are
western analysis of MEFs stably expressing FLAG and HA tagged HMGN variants. Endogenous and exogenous HMGN proteins are indicated.
C, control infection with empty virus; exp, experimental infection with indicated protein. Note comparable amounts of exogenous and endogenous
proteins for all cell lines. (B) PCA of gene expression proﬁles in infected MEFs. Each sample was analyzed in triplicate. Stably expressed proteins are
indicated. Each dot corresponds to individual pool of indicated HMGN variant. (C) The graph represents the number of genes changed following
stable expression of an HMGN protein, compared with the control empty vector expression. Note the negligible effect of HMGN3a and
HMGN5S17,21E on transcription. (D) Venn diagrams of down- and upregulated genes in infected MEFs. (E) The plot represents fold change in
transcription for all affected genes following HMGN1, HMGN2 and HMGN5 overexpression. Note that most of the genes are affected up to 2-fold.
Nucleic Acids Research, 2011,Vol.39, No. 10 4081or HMGN2, or HMGN5. The fourth cluster was formed
by cell lines overexpressing either the HMGN5-S17,21E
double-point mutant, cell transfected with an empty
vector, or by the cells overexpressing the HMGN3a
variant. These results demonstrate that in MEFs, each
HMGN variant has speciﬁc effects on transcription.
The cells differed not only in the speciﬁcity of genes
affected but also in the number of genes affected.
Doubling the levels of HMGN1, HMGN2 and HMGN5
affected the expression of 1268, 2753 and 3183 genes,
whereas HMGN3a and HMGN5-S17,21E caused no sig-
niﬁcant changes in gene expression. For HMGN1,
HMGN2 and HMGN5 proteins, the proportion of up-
and down regulated genes was roughly equal, indicating
that the proteins did not preferentially activate or inhibit
transcription (Figure 3C).
More detailed comparison of the genes affected by each
of the HMGN variants revealed that while each protein
either up- or downregulated the expression of a unique set
of genes, a fraction of the genes was affected by more than
one HMGN protein, suggesting partial redundancy in
transcriptional regulation (Figure 3D). Thus, of the 457
genes that were downregulated by overexpressing
HMGN1, 40% were uniquely affected, 17% were also
downregulated by HMGN5, 22% were also down-
regulated by HMGN2 and 21% were downregulated by
all three HMGNs. Of the 811 genes that were upregulated
in HMGN1-overexpressing cells, 44% were uniquely
affected, 12% were also affected by HMGN5, 31% were
also affected by HMGN2 and 13% were upregulated
by all the HMGNs. For HMGN2, a total of 1263 genes
were downregulated, of these 60% were speciﬁcally
downregulated only by HMGN2, and 24% were also
downregulated by HMGN5. Likewise,  50% of the
1490 genes were speciﬁcally upregulated by HMGN2
and  70% of the genes up- or downregulated by
HMGN5 were speciﬁcally affected by HMGN5.
Only a small proportion of the 5203 genes whose tran-
scription changed by overexpression of the HMGNs was
commonly affected by all the three HMGN proteins. In
all, 96 genes (2%) were downregulated and 103 (2%) were
upregulated. The most extensive overlap was observed
between HMGN1 and HMGN2 proteins; 44% of the
genes upregulated by HMGN1 were also upregulated by
HMGN2. We also found a large number of genes
regulated by both HMGN5 and HMGN2; 478 and 403
genes were up- and downregulated by both proteins, re-
spectively. While the total number of the genes whose
transcription levels changes was statistically signiﬁcant
was relatively large, the transcription levels of most of
the genes changed  2-fold (Figure 3E). These ﬁndings
are in agreement with previous studies indicating that
while HMGN proteins affect the expression of many
genes, the changes in transcription levels are relatively
small (19,27,50).
Next, we performed a functional analysis on the sets of
genes exclusively regulated by each individual protein, as
well as on the sets of genes regulated by combinations of
several proteins (Table 1) for signiﬁcantly overrepresented
GO terms. The results indicate that overexpression of in-
dividual HMGN variants affected gene from different
categories. Whereas HMGN1 affected genes involved in
cell division and mitosis, HMGN2 regulated genes
involved in regulation of transcription, development and
chromatin binding. Notably, genes involved in cell cycle
regulation were also preferentially affected in Hmgn1
 / 
MEFs (Figure 2B). HMGN5-induced transcriptional
changes were mainly associated with metabolic processes,
protein, metal ion and transcription factor binding. We
note, however, that the GO analysis suggests a certain
degree of redundancy among the HMGN variants. For
instance, GO term ‘response to virus’ (GO:0009615) was
enriched for genes commonly regulated by HMGN1 and
HMGN2 proteins. In addition, several biosynthetic
processes, such as sterol biosynthesis (GO:0016126),
cholesterol (GO:0006695) and lipid biosynthesis
(GO:0008610), and others were enriched for the genes
regulated by all three HMGN variants. In fact, of 199
genes regulated by all HMGNs, 52 genes are involved in
various biosynthetic processes.
Taken together, the gene expression proﬁles and the GO
analyses reveal a surprising degree of speciﬁcity in the
effects of the various HMGN variants on the cellular tran-
scription proﬁle. The functional redundancy among the
variants is lower than what would be expected from a
set of proteins with structural similarities, which bind to
nucleosomes with similar afﬁnities, have highly similar
NBDs and use an identical sequence motif to bind specif-
ically to nucleosome CPs.
Transcriptional effects of HMGN swap mutants
Because the N-terminal half of the HMGNs are highly
similar, while their C-terminal domains are clearly
distinct (Figure 1A), we assumed that the functional spe-
ciﬁcity of the proteins resides in their C-terminal region.
To test this assumption, we generated retroviral vectors
expressing tail swap mutants in which C-terminal region
of either HMGN2 or HMGN3a protein was fused to
N-terminal part of HMGN1 protein, immediately after
the conserved NBD (see Figure 1A for exact location of
the regions swapped). We named these mutants as N1–N2
swap and N1–N3 swap. The correct expression of the
swap mutants in MEFs infected with the retroviral
vectors was veriﬁed by western blot analysis (Figure 4A)
using an antibody elicited against the conserved NBD of
the HMGN protein family, which recognizes all the
HMGN variants (51).
The transcription proﬁle of the MEFs expressing the
swap mutants was determined by mouse 430.2 Affymetrix
expression arrays and compared with that of cells infected
with vectors expressing the native proteins.
Three-dimensional clustering of the results using PCA
(Figure 4B) revealed that the effect of the swap mutants
on transcription was distinct from that of their ‘source’
proteins. Thus, while HMGN3a did not affect transcrip-
tion (Figure 3) in MEFs, the N1–N3 swap mutant signiﬁ-
cantly affected the transcription of 1522 genes, most of
which were distinct from the genes affected by HMGN1
(Figure 4C, 3–4). Further comparison of the genes
affected by the swap mutants with the genes affected by
either HMGN1 or HMGN2 (Figure 4C) supported the
4082 Nucleic Acids Research, 2011,Vol.39, No. 10notion that transcriptional changes induced by the tail
swap mutants differed from those observed for HMGN1,
HMGN2 or HMGN3a proteins. The swap mutants specif-
ically downregulated 621 genes (Figure 4C 1,3) and
upregulated 402 genes (Figure 4C 2,4). Interestingly, the
two swap mutants had very similar effects on the cellular
transcription proﬁle (Figure 4D). Of the 1252 and the 1177
genes, respectively, downregulated by the N1–N2 and the
N1–N3 swap mutants, close to 80% genes overlapped.
Likewise, most of the genes that were up-regulated by the
N1–N2 swap mutant were also upregulated by the N1–N3
swap protein (Figure 4D). The similarity in the genes
regulatedbytheswapmutantspointsouttotheimportance
of their shared NBD region in determining the effect on the
transcription proﬁle. Yet, the effects were clearly distinct
from HMGN1, the donor of their shared NBD, an indica-
tion that ultimately, the structure of the entire protein, the
combination of individual N- and C-terminal domains, de-
termines the functional speciﬁcity of the HMGN variants.
Cell type-speciﬁc effects on transcription
Surprisingly, our analysis revealed that overexpression of
HMGN3a had no effect on transcription proﬁle of the
transfected MEFs. We previously reported that in MEFs
the protein levels of HMGN3 are lower than those of
HMGN1 and HMGN2 that are robustly expressed in
most cells. However, HMGN3a is highly expressed in
MIN6 cell, a mouse pancreatic cell line that secretes
insulin (19). In these cells, small interfering RNA-
mediated downregulation of HMGN3, but not that of
HMGN1 or HMGN2, affects the transcription of genes
involved in insulin secretion, suggesting that HMGN3a
may affect transcription in a cell type-speciﬁc manner.
To test this possibility, we ﬁrst re-examined the relative
amount of HMGN3 protein in MIN6 and MEF cells.
Western blot analyses revealed that indeed the HMGN3
protein levels in MIN6 were signiﬁcantly higher than in
MEFs (Figure 5A). Next, we infected MIN6 cells with
retroviral vectors expressing either HMGN1 or
Table 1. GO analysis of gene expression in MEFs with elevated HMGN levels
Gene set No. of
genes*
GO category Description Ontology P-value**
HMGN1 544 GO:0051301 Cell division BP 4.2e-05
GO:0007067 Mitosis BP 0.00066
GO:0008270 Zinc ion binding MF 0.038
HMGN2 1519 GO:0045449 Regulation of transcription BP 6.6e-06
GO:0005515 Protein binding MF 1.6e-05
GO:0000166 Nucleotide binding MF 0.00024
GO:0007507 Heart development BP 0.0009
GO:0006350 Transcription BP 0.0042
GO:0003682 Chromatin binding MF 0.0049
GO:0030324 Lung development BP 0.035
HMGN5 2130 GO:0005515 Protein binding MF 1.8e-09
GO:0016740 Transferase activity MF 1.3e-06
GO:0046872 Metal ion binding MF 9.1e-05
GO:0005524 ATP binding MF 0.0035
GO:0008152 Metabolic process BP 0.0046
GO:0003700 Sequence-speciﬁc DNA-binding transcription
factor activity
MF 0.0074
GO:0045449 Regulation of transcription BP 0.012
GO:0006974 Response to DNA damage stimulus BP 0.013
GO:0000166 Nucleotide binding MF 0.015
GO:0016310 Phosphorylation BP 0.036
GO:0019838 Growth factor binding MF 0.048
GO:0042802 Identical protein binding MF 0.049
HMGN1/HMGN2 353 GO:0009615 Response to virus BP 3.2e-06
HMGN2/HMGN5 682 GO:0007155 Cell adhesion BP 6.6e-05
GO:0008201 Heparin binding MF 0.0028
GO:0005515 Protein binding MF 0.017
HMGN1/HMGN2/HMGN5 199 GO:0016126 Sterol biosynthetic process BP 5.3e-20
GO:0006695 Cholesterol biosynthetic process BP 6.9e-18
GO:0006694 Steroid biosynthetic process BP 9.1e-17
GO:0008610 Lipid biosynthetic process BP 3e-15
GO:0008299 Isoprenoid biosynthetic process BP 2.9e-09
GO:0006418 tRNA aminoacylation for protein translation BP 0.00035
GO:0004812 aminoacyl-tRNA ligase activity MF 0.0029
GO:0003824 Catalytic activity MF 0.0035
GO:0016874 Ligase activity MF 0.0037
GO:0019287 Isopentenyl diphosphate biosynthetic process,
mevalonate pathway
BP 0.011
GO:0055114 Oxidation–reduction process BP 0.027
GO:0016491 Oxidoreductase activity MF 0.037
BP, biological process; MF, molecular function.
* sets are exclusive.
** signiﬁcance threshold is 0.05.
Nucleic Acids Research, 2011,Vol.39, No. 10 4083HMGN3a proteins and veriﬁed protein expression by
western blot analysis (Figure 5B and C).Transcriptional
array analysis revealed that in MIN6 cells, HMGN3a sig-
niﬁcantly changed the expression of 1429 genes; of these
471 were up-regulated and 958 genes were down-regulated
(Figure 5D). In contrast, overexpression of HMGN1 in
MIN6 cell line had no signiﬁcant effect on the transcrip-
tion proﬁle. Because HMGN1 had signiﬁcant effects on
the transcription proﬁle of MEFs (Figure 3), these results
suggest cell type-speciﬁc transcription effects of HMGN
variants.
DISCUSSION
The major goal of this study is to examine whether the
various members of the HMGN protein family can af-
fect the cellular transcription proﬁle in an HMGN-
variant-speciﬁc manner. Although previous studies
indicated that the binding of HMGN protein to chromatin
alters the cellular transcription proﬁle, the degree to which
these changes are HMGN-variant speciﬁc has not yet been
investigated.
The dynamic nature of HMGN binding to chromatin
and the lack of any DNA sequence speciﬁcity in their
chromatin interactions, taken together with the conserva-
tion of their nuclear-binding domain and similarities in
their overall organization and physical properties, raised
the possibility that the individual HMGN variants would
be functionally redundant and have similar effects on the
cellular transcription proﬁle. Conversely, the widespread
expression of HMGN1 and HMGN2, but not HMGN3
and HMGN5, in most tissues and the sequence speciﬁcity
of their C-terminal domains suggest that potentially the
proteins may have variant-speciﬁc effects on the transcrip-
tion proﬁle. Indeed, in vitro experiments revealed
variant-speciﬁc effects on histone modiﬁcations, and ex-
periments with genetically altered mice also suggest that
the HMGN variants are not fully functionally redundant.
Figure 4. Comparison of the effect of HMGN tail swap mutants on transcription in MEFs. (A) Western blot analysis of MEFs stably expressed
swap mutants using an antibody that recognizes the conserved NBD. N1, endogenous HMGN1; c, control expression of empty vector. (B) PCA
of gene expression proﬁles in MEFs. Each sample was analyzed in triplicate. Stably expressed proteins are indicated. Each dot corresponds to
individual pool of indicated HMGN variant. (C) Venn diagrams of down- and upregulated genes in stable cell lines comparing N1-N2 swap (1,2)
or N1-N3 swap (3,4) with HMGN1 and HMGN2 proteins. (D) Venn diagrams of down- and up-regulated genes in cells expressing tail swap mutant
proteins.
4084 Nucleic Acids Research, 2011,Vol.39, No. 10Our experiments suggest that each HMGN variant
can affect the expression of numerous genes, especially
when overexpressed, and by enlarge in an
HMGN-speciﬁc manner. The amplitude of transcription-
al changes was moderate; for most of the affected genes
being in the limits of 2-fold difference. Importantly,
nearly equal amount of genes were either up- or
downregulated by each HMGN, suggesting that
HMGNs are neither transcriptional activators nor re-
pressors. The GO analyses indicated that multiple
cellular processes were affected by individual HMGNs
or by combinations of several HMGNs, suggesting that
the HMGNs are general modulators of the cellular tran-
scriptional ﬁdelity.
Two molecular mechanisms whereby HMGN affect the
transcription proﬁle could be envisioned. One possibility is
that by binding to nucleosomes, HMGN induce structural
changes that alter the ability of transcriptional regulators,
either positive or negative, to interact with their chromatin
targets. A second possibility is that the HMGN interact
with speciﬁc regulators and affect their chromatin inter-
actions. Both possibilities suggest that the ability of
HNGN variants to bind to chromatin is a major effect
on the transcriptional output. Indeed, our previous ex-
periments (50), and our present analyses of the
HMGN5-S19,23E mutant, indicate that HMGNs affect
transcription by binding to nucleosomes.
While nucleosome binding seems to be an absolute re-
quirement for any noticeable effects on transcription, the
variant-speciﬁc effects on the transcription proﬁle suggest
that additional properties of these proteins play a role in
determining their biological speciﬁcity. Because the
C-terminal domain of HMGNs is highly variable in
sequence between individual HMGN proteins, we tested
the possibility that the speciﬁc transcriptional effects of
HMGNs reside in this domain and expressed several
HMGN swap mutants in MEF cells. Surprisingly, the
transcriptional outcome following the expression of
these swap mutants with a common NBD from
HMGN1, and a C-terminal domain from HMGN1,
HMGN2 or HMGN3 was different from either one of
their ‘source’ proteins. Thus, the variant-speciﬁc effects
of HMGNs on transcription are the consequence of
coordinate effects of the various structural domains of
each variant. In other words, neither the NBD nor the
C-terminal domain alone deﬁnes the transcriptional
effect of each HMGN protein, but rather the entire struc-
ture of the protein deﬁnes its speciﬁc role in transcription
(Figure 5E).
In considering the molecular mechanisms leading
to HMGN-variant-speciﬁc effects on transcription, we Figure 5. Effect of HMGN1 and HMGN3a on transcription in MIN6
cells. (A) Comparison of the protein levels of HMGN3 and HMGN1 in
MIN6 and MEFs by western blot. CBB, Coomassie Blue staining.
Western blot analysis of MIN6 cell lines stably expressing HMGN1
(B) or HMGN3a (C) proteins. Endogenous and exogenous FLAG
and HA tagged (FLHA) proteins are indicated. c, control infection
with empty virus; exp, experimental infection with indicated protein.
The graph (D) represents the number of genes changed following
overexpression of HMGN1 and HMGN3a proteins compared with
the control empty vector expression. (E) Model for structural speciﬁcity
of individual HMGN proteins. HMGN proteins consist of a conserved
N-terminal region, which contains the NBD and the conserved
octapeptide, RRSARLSA and a C-terminal region with a more
variable sequence. The N- and C-terminal regions of each HMGN
variant ﬁt to give the speciﬁc property of each variant. Arrow marks
the hypothetical connection between N- and C-regions; the geometry
indicates unique combination of regions in each HMGN protein. Both
the N- and the C-terminal regions interact with various protein
partners. Some partners are shared between all HMGNs, whereas
others are speciﬁc to individual proteins. Combinations of different
interacting proteins will deﬁne the properties of each HMGN protein
and its ability to affect chromatin architecture and transcription.
Nucleic Acids Research, 2011,Vol.39, No. 10 4085note that early structural studies indicated that HMGNs
have little ordered structure (52), and our computation-
al analysis (Figure 1) reveal that HMGNs are among the
most intrinsically disordered proteins known. Intrinsically
disordered proteins can interact with multiple protein
partners with relatively low afﬁnity and acquire more
ordered structures (45–47,53–58). It has been recently
reported that the harmful effect of elevated cellular
levels of many proteins is correlated with the degree of
their disorderness (25). At the same time, cells with
decreased amount of these proteins function robustly
and do not demonstrate signiﬁcant changes in cellular
functions. Our observation that knock out of HMGNs
has signiﬁcantly smaller effect on transcription supports
this theory and strongly argues that disordered structure
of HMGNs is one of the major functional properties of
these proteins.
Variations in structure of HMGN proteins due to
interaction with different protein partners can modulate
the effects of HMGN variants on local nucleosome struc-
ture, global chromatin architecture and transcription
(Figure 5E). Indeed, both HMGN1 and HMGN2 have
been shown to form multiple metastable macromolecular
complexes (15), and speciﬁc protein partners have been
identiﬁed for several HMGN variants. Thus, HMGN3
interacts speciﬁcally with the thyroid hormone receptor
(59) and with the transcription factor PDX1 (19),
HMGN1 forms a complex with ERalpha and SRF
(15), and HMGN2 was shown to interact with PITX2
(60). Our observation of cell-speciﬁc effects of HMGN3a
protein on transcription in the pancreatic derived MIN6
cell line, but not in MEFs (19), supports the idea of
existence of speciﬁc protein partners for individual
HMGN proteins.
In conclusion, our results reveal both speciﬁc and re-
dundant roles of HMGN variants in the global regula-
tion of gene expression. Each HMGN preferentially
affects a unique set of genes with little or no speciﬁcity
for deﬁned cellular processes. Thus, changes in the ex-
pression of an HMGN may disrupt the ﬁdelity of the
cellular transcription and render the organism more sus-
ceptible to further damage. Indeed, experiments with
genetically altered mice and with cells derived from
these mice indicate that loss of HMGN1 leads to an
impaired DNA damage repair response and increased
tumorigenicity (27,49,61). Likewise, loss of HMGN3,
which is highly expressed in beta cells of the pancreatic
islets, affects insulin secretion leading to a mild diabetic
phenotype (19). The transcriptional speciﬁcity of the
HMGN variants is similar to that of the H1 variants.
It seems that the dynamic interaction of HMGN, H1
and other structural proteins with chromatin is part of
the mechanism that ultimately ﬁne tunes the transcrip-
tion proﬁle to optimize cellular function.
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